The CHF FAQ on Diastolic Heart Failure References : 1. Zile MR. Diastolic heart failure: diagnosis, mechanisms, and treatment. Cardiol Rounds. 1999;3:1-8 2. Gaasch WH, Schick EC, Zile MR. Management of left ventricular diastolic dysfunction. In: Smith TW, ed. Cardiovascular Therapeutics. A Companion to Braunwald's Heart Disease. Philadelphia, Pa: WB Saunders; 1996:237-242 3. Brutsaert DL, Sys SU, Gillebert TC. Diastolic failure: pathophysiology and therapeutic implications. J Am Coll Cardiol. 1993;22:318-325 4. Gaasch WH. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA. 1994;271:1276-1280 5. Udelson JE, Bonow RO, O'Gara PT, et al. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation. 1989;79:1052-1060 6. Paulus WJ, Bronzwaer JGF, de Bruyne B, Grossman W. Different effects of "supply" and "demand" ischemia on left ventricular diastolic function in humans. In: Gaasch WH, LeWinter MM, eds. Left Ventricular Diastolic Dysfunction and Heart Failure. Philadelphia, Pa: Lea & Febiger; 1994:286 7. Rakowski H, Appleton C, Chan KL, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr. 1996;9:736-760 8. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J. 1998;19:990-1003 9. Vasan RS, Levy D. Defining diastolic heart failure. Circulation. 2000;101:2118-2121. Editorial 10. Echeverria HH, Bilsker MS, Myerburg RJ, Kessler KM. Congestive heart failure: echocardiographic insights. Am J Med. 1983;75:750-755 11. Rossvoll O, Hatle LK. Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures. J Am Coll Cardiol. 1993;21:1687-1696 12. Cohn JN, Johnson G, and the Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction. The V-HeFT study. Circulation. 1990;81(suppl III):48-53 13. Luchi RJ, Snow E, Luchi JM, et al. Left ventricular function in hospitalized geriatric patients. J Am Geriatr Soc. 1982;30:700-705 14. Wong WF, Gold S, Fukuyama O, Blanchette PL. Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol. 1989;63:1526-1528 15. Setaro JF, Soufer R, Remetz MS, et al. Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol. 1992;69:1212-1216 16. Judge KW, Pawitan Y, Caldwell J, et al. Congestive heart failure symptoms in patients with preserved left ventricular systolic function: analysis of the CASS registry. J Am Coll Cardiol. 1991;18: 377-382 17. Brogan WC III, Hillis LD, Flores ED, Lange RA. The natural history of isolated left ventricular diastolic dysfunction. Am J Med. 1992;92:627-630 18. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282-2289 19. Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948-1955 20. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525-533 21. Bonow RO, Dilsizian V, Rosing DR, et al. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term results. Circulation. 1985;72: 853-864 22. Setaro JF, Zaret BL, Schulman DS, et al. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol. 1990;66:981-986 23. Warner JG Jr, Metzger DC, Kitzman DW, et al. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol. 1999; 33:1567-1572 24. Liu CP, Ting CT, Lawrence W, et al. Diminished contractile response to increased heart rate in intact human left ventricular hypertrophy. Systolic versus diastolic determinants. Circulation. 1993;88(4 Pt 1):1893-1906 25. Mulieri LA, Hasenfuss G, Leavitt B, et al. Altered myocardial force-frequency relation in human heart failure. Circulation. 1992;85:1743-1750 26. Levine HJ. Optimum heart rate of large failing hearts. Am J Cardiol. 1988;61:633-636 27. Hoit BD, Walsh RA. Diastolic function in hypertensive heart disease. In: Gaasch WH, LeWinter MM, eds. Left Ventricular Diastolic Dysfunction and Heart Failure. Philadelphia, Pa: Lea & Febiger; 1994:354 28. Packer M. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. Circulation. 1990;81(suppl III): 78-86 29. Lorell BH, Isoyama S, Grice WN, et al. Effects of ouabain and isoproterenol on left ventricular diastolic function during low-flow ischemia in isolated, blood-perfused rabbit hearts. Circ Res. 1988;63: 457-467 30. Lang RM, Carroll JD, Nakamura S, et al. Role of adrenoreceptors and dopamine receptors in modulating left ventricular diastolic function. Circ Res. 1988;63:126-134